Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel inhibitors of Src kinases developed at Roche

June 21, 2004

New phase II trial studies talabostat for advanced metastatic melanoma

June 21, 2004

ILX-651 in new phase II trial for hormone-refractory prostate cancer

June 21, 2004

New CDK inhibitors in early development at Banyu

June 18, 2004

Antiangiogenic HARP-derived peptides newly developed at CNRS

June 18, 2004

Labopharm to apply polymeric nanodelivery systems technology to cancer drug

June 18, 2004

Phase II trial of Xcytrin for recurrent low-grade NHL under way

June 18, 2004

Efaproxyn and Revaproxyn, new trade names for efaproxiral

June 18, 2004

OSI and Genentech sign new Tarceva agreements

June 18, 2004

Clinical efficacy of a BAY-43-9006 combination regimen in advanced melanoma

June 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...